Published in Life Sci on May 04, 1987
Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun (1989) 3.03
Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun (1971) 2.67
Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971) 2.43
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun (1971) 2.29
Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science (1975) 2.00
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study. Dig Dis Sci (1989) 1.56
Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc Natl Acad Sci U S A (1980) 1.54
Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun (1990) 1.52
Alpha 1-antitrypsin deficiency and chronic pancreatitis. Dig Dis Sci (1995) 1.48
The regional distribution of somatostatin in the rat brain. Endocrinology (1975) 1.48
Isolation and structure of somatostatin from porcine hypothalami. Biochemistry (1976) 1.46
Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol (2002) 1.44
Solid phase synthesis of growth hormone-release inhibiting factor. Biochem Biophys Res Commun (1973) 1.44
Hypothalamic regulatory hormones. Science (1973) 1.41
Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol (1974) 1.40
Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res (1968) 1.36
Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril (1971) 1.35
Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) (1975) 1.34
Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology (1987) 1.31
Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest (1978) 1.31
The hypothalamus and reproduction. Am J Obstet Gynecol (1972) 1.29
Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med (1975) 1.27
Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol (1998) 1.26
Endoscopic removal of a toothbrush. Gastrointest Endosc (1983) 1.25
LH-RH agonists and antagonists. Int J Gynaecol Obstet (1980) 1.24
Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med (2006) 1.23
Radioimmunoassay of somatostatin. Metabolism (1978) 1.22
Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest (1977) 1.22
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat (2004) 1.19
Stimulation of release and synthesis of luteinizing hormone(LH) and follicle stimulating hormone(FSH) in tissue culture of rat pituitaries in response to natural and synthetic LH and FSH releasing hormone. Endocrinology (1972) 1.17
Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Physiol (1990) 1.16
Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience (1992) 1.14
Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun (1976) 1.12
Letter: Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem (1975) 1.12
Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem (2000) 1.12
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat (2008) 1.11
Thrombocytosis in patients with celiac sprue. Gastroenterology (1976) 1.10
Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology (1974) 1.10
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect (2002) 1.09
Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. Lancet (1982) 1.09
Effect of jejunal amino acid perfusion and exogenous cholecystokinin on the exocrine pancreatic and biliary secretions in man. Gastroenterology (1971) 1.07
Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology (1990) 1.07
Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. J Med Chem (1971) 1.05
Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem (1994) 1.05
Effect of intraventricular injection of dopamine, noreprinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology (1979) 1.05
Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami. J Biol Chem (1971) 1.05
Immunohistochemical localization of somatostatin (growth hormone release-inhibiting factor) in the guinea pig brain. Brain Res (1974) 1.05
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther (1993) 1.04
Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation (1995) 1.03
Evidence for peptide nature of LH and FSH-releasing hormones. Biochem Biophys Res Commun (1971) 1.03
Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides (2002) 1.03
Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol (1981) 1.02
Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res (1996) 1.02
Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc (1986) 1.02
Production of antiserum to LH-releasing hormone (LH-RH) associated with gonadal atrophy in rabbits: development of radioimmunoassays for LH-RH. Endocrinology (1973) 1.01
Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke (2000) 1.01
p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci (1997) 1.01
Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res (1997) 1.00
Release of LH and FSH after administration of synthetic LH-releasing hormone. J Clin Endocrinol Metab (1972) 1.00
Postischemic spontaneous hyperthermia and its effects in middle cerebral artery occlusion in the rat. Exp Neurol (2000) 0.99
Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res (1994) 0.98
Blockade of release of growth hormone by brain norepinephrine depletors. Endocrinology (1967) 0.98
Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 0.98
Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science (1980) 0.98
Electron microscopic immunohistochemical localization of growth hormone-release inhibiting hormone (somatostatin) in the rat median eminence. Am J Anat (1974) 0.98
Recent approaches to fertility control based on derivative of LH-RH. Vitam Horm (1980) 0.97
Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology (1991) 0.97
Fas ligand expression in esophageal carcinomas and their lymph node metastases. Cancer (2000) 0.96
Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Biochem Biophys Res Commun (1977) 0.96
The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest (1977) 0.95
Effect of different acid treatments on a porcelain surface. J Oral Rehabil (2001) 0.95
Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta (1992) 0.95
Anti-NADase values in rheumatic fever and valvular disease. Jpn Circ J (1984) 0.95
Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology (1977) 0.95
Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun (1990) 0.95
An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs. Acta Endocrinol (Copenh) (1977) 0.94
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett (1990) 0.94
Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res (1997) 0.94
Ulcerative colitis in Turkey: clinical review of sixty cases. Dis Colon Rectum (1970) 0.94
Comparison of midazolam sedation with or without fentanyl in cataract surgery. Acta Anaesthesiol Belg (2008) 0.94
Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood. Endocrinology (1981) 0.94
Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology (1991) 0.92
Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology (1988) 0.92
Stimulation of ACTH release by human interleukin-1 beta, but not by interleukin-1 alpha, in conscious, freely-moving rats. Biochem Biophys Res Commun (1987) 0.92
Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am J Physiol (1989) 0.92
Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Gastroenterology (1996) 0.92
In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin. Peptides (1982) 0.92
Paracrine regulation of gastric acid secretion by fundic somatostatin. Am J Physiol (1987) 0.91
Studies on retarded growth of rats with hereditary hypothalamic diabetes insipidus. Neuroendocrinology (1968) 0.91
Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog. Am J Gastroenterol (1982) 0.91
Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology (1991) 0.90
Effect of stress on circadian periodicity in serum LH and prolactin concentration. Endocrinology (1972) 0.90
Hypoglycemia, stress and growth hormone release: blockade of growth hormone release by drugs acting on the central nervous system. Endocrinology (1967) 0.90
Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Cancer Epidemiol Biomarkers Prev (1997) 0.90
Dual inhibitory pathways link antral somatostatin and histamine secretion in human, dog, and rat stomach. Gastroenterology (1995) 0.90
Interleukin-1 beta increases prostaglandin E2 in rat astrocyte cultures: modulatory effect of neuropeptides. Endocrinology (1989) 0.89
Effect of PACAP on gastric acid secretion in rats. Peptides (1995) 0.89